Marinus Pharmaceuticals, Inc.
CAGE Code: 4BX80
NCAGE Code: 4BX80
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 141007232
Summary
Marinus Pharmaceuticals, Inc. is an Active Commercial Supplier with the Cage Code 4BX80 and is tracked by Dun & Bradstreet under DUNS Number 141007232..
Address
5 Radnor Corporate Center
100 W Matsonford Rd Ste 500
Radnor PA 19087-5279
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Xpect Solutions Federal Llc Newspring Holdings Ii Gp, Llc Trailer Fleet International Llc Spectrum Information Managment Nexlyte, Inc. Jtk Consulting, Llc Turner & Townsend Heery, Llc Brandywine Operating Partnership, Brandywine Realty Services Corp Brandywine Operating Partnership, Fuller Equipment Group Inc Optical Devices Inc Medical Diagnostic Research Main Line Drilling Company Global Environmental Health Tim Calvin Access Controls Inc The Prima Group Data View, Inc. Chem Fluid Solutions, Llc Airgas Medical Services, Inc.
Frequently Asked Questions (FAQ) for CAGE 4BX80
- What is CAGE Code 4BX80?
- 4BX80 is the unique identifier used by NATO Organizations to reference the physical entity known as Marinus Pharmaceuticals, Inc. located at 5 Radnor Corporate Center, 100 W Matsonford Rd Ste 500, Radnor PA 19087-5279, United States.
- Who is CAGE Code 4BX80?
- 4BX80 refers to Marinus Pharmaceuticals, Inc. located at 5 Radnor Corporate Center, 100 W Matsonford Rd Ste 500, Radnor PA 19087-5279, United States.
- Where is CAGE Code 4BX80 Located?
- CAGE Code 4BX80 is located in Radnor, PA, USA.
Contracting History for CAGE 4BX80 Most Recent 25 Records
- 36F79724D0030
- 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, Fss Contract Award
- 20 Nov 2023
- 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, Fss Contract Award
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 36F79724D0030
- Public Law 2024
- 4 Dec 2023
- Public Law 2024
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 36F79723D019E
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products
- 28 Nov 2023
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 36F79723D019E
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products
- 17 Nov 2023
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 36F79723D019E
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products
- 21 Jun 2023
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 75A50120C00159
- Development Of Intravenous Drug Ganaxolone
- 12 Sep 2023
- Development Of Intravenous Drug Ganaxolone
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $33,656,933.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00159
- Development Of Intravenous Drug Ganaxolone
- 2 Jan 2024
- Development Of Intravenous Drug Ganaxolone
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $33,656,933.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00159
- Development Of Intravenous Drug Ganaxolone
- 19 Sep 2022
- Development Of Intravenous Drug Ganaxolone
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $33,656,933.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00159
- Development Of Intravenous Drug Ganaxolone
- 22 Mar 2022
- Development Of Intravenous Drug Ganaxolone
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $21,338,880.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00159
- Development Of Intravenous Drug Ganaxolone
- 24 Mar 2023
- Development Of Intravenous Drug Ganaxolone
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $33,656,933.00
- Department Of Health And Human Services (Hhs)